Marionneau-Lambot S - Search Results

1

Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies.

Berdal M, Gouard S, Eychenne R, Marionneau-Lambot S, Croyal M, Faivre-Chauvet A, Chérel M, Gaschet J, Gestin JF, Guérard F. Berdal M, et al. Chem Sci. 2020 Nov 23;12(4):1458-1468. doi: 10.1039/d0sc05191h. Chem Sci. 2020. PMID: 34163909 Free PMC article.

2

ImmunoPET in Multiple Myeloma-What? So What? Now What?

Bailly C, Chalopin B, Gouard S, Carlier T, Saëc PR, Marionneau-Lambot S, Moreau P, Touzeau C, Kraeber-Bodere F, Bodet-Milin C, Chérel M. Bailly C, et al. Cancers (Basel). 2020 Jun 4;12(6):1467. doi: 10.3390/cancers12061467. Cancers (Basel). 2020. PMID: 32512883 Free PMC article.

3

Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease.

Gouard S, Maurel C, Marionneau-Lambot S, Dansette D, Bailly C, Guérard F, Chouin N, Haddad F, Alliot C, Gaschet J, Eychenne R, Kraeber-Bodéré F, Chérel M. Gouard S, et al. Cancers (Basel). 2020 Sep 22;12(9):2721. doi: 10.3390/cancers12092721. Cancers (Basel). 2020. PMID: 32971984 Free PMC article.

4

Cyclam-Based Chelators Bearing Phosphonated Pyridine Pendants for ⁶⁴Cu-PET Imaging: Synthesis, Physicochemical Studies, Radiolabeling, and Bioimaging.

Knighton RC, Troadec T, Mazan V, Le Saëc P, Marionneau-Lambot S, Le Bihan T, Saffon-Merceron N, Le Bris N, Chérel M, Faivre-Chauvet A, Elhabiri M, Charbonnière LJ, Tripier R. Knighton RC, et al. Inorg Chem. 2021 Feb 15;60(4):2634-2648. doi: 10.1021/acs.inorgchem.0c03492. Epub 2021 Jan 26. Inorg Chem. 2021. PMID: 33496592

5

Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety.

Delage JA, Gnesin S, Prior JO, Barbet J, Le Saëc P, Marionneau-Lambot S, Gouard S, Chérel M, Bourgeois M, Schaefer N, Viertl D, Fierle JK, Dunn SM, Faivre-Chauvet A. Delage JA, et al. Among authors: marionneau lambot s. Cancers (Basel). 2021 Nov 25;13(23):5936. doi: 10.3390/cancers13235936. Cancers (Basel). 2021. PMID: 34885044 Free PMC article.

6

Highly inert Cu(II) complexes of C-aryl bifunctional cyclam-picolinates with remarkable ⁶⁴Cu-labelling and biodistribution.

Pineau J, Lima LMP, Le Roy MM, Marionneau-Lambot S, Cordier M, Le Saëc P, Zeevaart JR, Driver CHS, Faivre-Chauvet A, Le Bris N, Tripier R. Pineau J, et al. Among authors: marionneau lambot s. Chem Commun (Camb). 2023 Jan 19;59(7):888-891. doi: 10.1039/d2cc06602e. Chem Commun (Camb). 2023. PMID: 36598060

7

PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance.

Tessoulin B, Descamps G, Moreau P, Maïga S, Lodé L, Godon C, Marionneau-Lambot S, Oullier T, Le Gouill S, Amiot M, Pellat-Deceunynck C. Tessoulin B, et al. Blood. 2014 Sep 4;124(10):1626-36. doi: 10.1182/blood-2014-01-548800. Epub 2014 Jul 8. Blood. 2014. PMID: 25006124 Free article.

8

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma.

Kervoëlen C, Ménoret E, Gomez-Bougie P, Bataille R, Godon C, Marionneau-Lambot S, Moreau P, Pellat-Deceunynck C, Amiot M. Kervoëlen C, et al. Oncotarget. 2015 Sep 29;6(29):26922-34. doi: 10.18632/oncotarget.4616. Oncotarget. 2015. PMID: 26323097 Free PMC article.

9

3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.

Hunault J, Diswall M, Frison JC, Blot V, Rocher J, Marionneau-Lambot S, Oullier T, Douillard JY, Guillarme S, Saluzzo C, Dujardin G, Jacquemin D, Graton J, Le Questel JY, Evain M, Lebreton J, Dubreuil D, Le Pendu J, Pipelier M. Hunault J, et al. J Med Chem. 2012 Feb 9;55(3):1227-41. doi: 10.1021/jm201368m. Epub 2012 Feb 1. J Med Chem. 2012. PMID: 22243602

10

Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo.

Joalland N, Lafrance L, Oullier T, Marionneau-Lambot S, Loussouarn D, Jarry U, Scotet E. Joalland N, et al. Oncoimmunology. 2019 Aug 28;8(11):e1649971. doi: 10.1080/2162402X.2019.1649971. eCollection 2019. Oncoimmunology. 2019. PMID: 31646097 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page